Bromhexine Hcl / Phenylephrine Hcl Tablet Suppliers & Bulk Manufacturers
Available Forms: Tablets
Available Strengths: 8mg +5mg
Reference Brands: Generic formulations marketed under different names
Category:
Respiratory Disorder
BROMHEXINE+PHENYLEPHRINE is a combination of two drugs: Bromhexine (mucolytic agent) and Phenylephrine (decongestant). Bromhexine is a mucolytic agent (cough/sputum thinner) that works by thinning and loosening phlegm (mucus) in the lungs, windpipe, and nose. Thus, it helps to cough out easily. Phenylephrine is a decongestant that works by contracting and narrowing the blood vessels. Therefore, it provides relief from congestion and decreases mucus production.
Bromhexine HCl / Phenylephrine HCl Tablet is available in Tablets
and strengths such as 8mg +5mg.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Bromhexine HCl / Phenylephrine HCl Tablet is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Bromhexine HCl / Phenylephrine HCl Tablet can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Bromhexine Hydrochloride and Phenylephrine Hydrochloride is a combination medication commonly used for the symptomatic relief of respiratory conditions such as the common cold, bronchitis, and upper respiratory tract infections. This combination works through a dual mechanism of action: Bromhexine Hydrochloride acts as a mucolytic agent, helping to break down and thin thick mucus in the airways, making it easier to cough out, while Phenylephrine Hydrochloride functions as a nasal decongestant by constricting blood vessels in the nasal passages, thereby reducing swelling and congestion.
Together, these actions help improve breathing, reduce chest congestion, and provide relief from blocked nose and productive cough. This medication is widely used in both tablet and syrup forms across various markets. It is generally well tolerated, but some individuals may experience mild side effects such as nausea, dizziness, headache, or gastrointestinal discomfort. It should be used under medical guidance, especially in patients with hypertension, cardiovascular conditions, or those taking other decongestant medications.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing